25-Hydroxycholesterol is a potent SARS-CoV-2 inhibitor

Cell Res. 2020 Nov;30(11):1043-1045. doi: 10.1038/s41422-020-00398-1. Epub 2020 Aug 18.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Angiotensin-Converting Enzyme 2
  • Animals
  • Betacoronavirus / drug effects*
  • Betacoronavirus / genetics*
  • COVID-19
  • Chlorocebus aethiops
  • Coronavirus Infections / blood
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / virology
  • Disease Models, Animal
  • Fatal Outcome
  • Female
  • Humans
  • Hydroxycholesterols / blood*
  • Hydroxycholesterols / pharmacology*
  • Mice
  • Mice, Inbred BALB C
  • Mice, Transgenic
  • Pandemics
  • Peptidyl-Dipeptidase A / genetics
  • Pneumonia, Viral / blood
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / virology
  • Reverse Transcriptase Polymerase Chain Reaction
  • SARS-CoV-2
  • Vero Cells
  • Virus Replication / drug effects

Substances

  • Hydroxycholesterols
  • 25-hydroxycholesterol
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Ace2 protein, mouse
  • Angiotensin-Converting Enzyme 2